Interferons: potential roles in affect

被引:23
作者
Hurlock, EC [1 ]
机构
[1] Columbia Univ, New York, NY USA
关键词
D O I
10.1054/mehy.2000.1218
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A review of the literature on interferons was conducted and possible roles in neuropsychiatric disorders with affective disturbances are assessed. Interferons and interferon receptors are present in the limbic system where they appear to exert physiological effects pertinent to affect, most potently when levels rise during CNS infections. Interferons interact closely with cytokines and nitric oxide, signaling molecules implicated in depression. Results from knock-out mice suggest a role for interferon-gamma in moderating fear and anxiety, while other lines of evidence point to a role in arousal and circadian rhythms. The interferon-alpha receptor deploys an arginine methyltransferase affecting RNA editing and splicing, which seem to be disrupted in schizophrenia and bipolar disorder. S-Adenosylmethionine (SAMe), an effective antidepressant, may owe its effects in the latter disorders in part to variations in the strength of interferon-alpha signaling impacting RNA processing. Antiviral effects of interferons are of interest in lieu of viral theories of affective disorders. Finally, the relative levels of interferons gamma and alpha might play important roles in neural, and glial, development, as well as the dialog between the CNS and the immune system. (C) 2001 Harcourt Publishers Ltd.
引用
收藏
页码:558 / 566
页数:9
相关论文
共 94 条
[41]   New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism [J].
Horrobin, DF ;
Bennett, CN .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1999, 60 (03) :141-167
[42]   Altered ratios of alternatively spliced long and short γ2 subunit mRNAs of the γ-amino butyrate type A receptor in prefrontal cortex of schizophrenics [J].
Huntsman, MM ;
Tran, BV ;
Potkin, SG ;
Bunney, WE ;
Jones, EG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :15066-15071
[43]  
JANICKI PK, 1992, RES COMMUN CHEM PATH, V75, P117
[44]   COMBINED ALPHA-INTERFERON AND GAMMA-INTERFERON THERAPY FOR MALIGNANT MIDGUT CARCINOID-TUMORS - A PHASE-I-II TRIAL [J].
JANSON, ET ;
KAUPPINEN, HL ;
OBERG, K .
ACTA ONCOLOGICA, 1993, 32 (02) :231-233
[45]   PHASE-III TRIAL OF RECOMBINANT INTERFERON-GAMMA IN COMPLETE RESPONDERS WITH SMALL-CELL LUNG-CANCER [J].
JETT, JR ;
MAKSYMIUK, AW ;
SU, JQ ;
MAILLIARD, JA ;
KROOK, JE ;
TSCHETTER, LK ;
KARDINAL, CG ;
TWITO, DI ;
LEVITT, R ;
GERSTNER, JB .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (11) :2321-2326
[46]  
JONAKAIT GM, 1994, NEURON, V12, P1149
[47]   Identification and mapping of a novel human gene, HRMT1L1, homologous to the rat protein arginine N-methyltransferase 1 (PRMT1) gene [J].
Katsanis, N ;
Yaspo, ML ;
Fisher, EMC .
MAMMALIAN GENOME, 1997, 8 (07) :526-529
[48]  
Ketter TA, 1996, ARCH GEN PSYCHIAT, V53, P59
[49]   GAMMA-INTERFERON-LIKE IMMUNOREACTIVE MATERIAL IN RAT NEURONS - EVIDENCE AGAINST A CLOSE RELATIONSHIP TO GAMMA-INTERFERON [J].
KIEFER, R ;
HAAS, CA ;
KREUTZBERG, GW .
NEUROSCIENCE, 1991, 45 (03) :551-560
[50]   The influence of a targeted deletion of the IFNγ gene on emotional behaviors [J].
Kustova, Y ;
Sei, Y ;
Morse, HC ;
Basile, AS .
BRAIN BEHAVIOR AND IMMUNITY, 1998, 12 (04) :308-324